| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/02/2001 | CA2394039A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393912A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393652A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393618A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393002A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392757A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392751A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392438A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392428A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392422A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392398A1 Nucleic acids, proteins, and antibodies |
| 08/01/2001 | EP1120466A2 Use of negative regulation elements for nerve-specific expression of transgenes |
| 08/01/2001 | EP1119643A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF TUMOR NECROSIS FACTOR-$g(a) (TNF-$g(a)) EXPRESSION |
| 08/01/2001 | EP1119642A1 Compounds and methods for enhancing delivery of free polynucleotide |
| 08/01/2001 | EP1119630A1 Nucleic acid constructs for genetic immunisation |
| 08/01/2001 | EP1119629A2 Oxidoreductase molecules |
| 08/01/2001 | EP1119619A2 Nlk1 -interacting proteins |
| 08/01/2001 | EP1119618A2 Stress promoter control of therapeutic genes in gene therapy: compositions and methods |
| 08/01/2001 | EP1119615A1 PRODUCTION OF ssDNA IN VIVO |
| 08/01/2001 | EP1119584A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 08/01/2001 | EP1119581A1 METHODS OF INHIBITING SMOOTH MUSCLE CELL PROLIFERATION AND PREVENTING RESTENOSIS WITH A VECTOR EXPRESSING RB2/p130 |
| 08/01/2001 | EP1119580A1 ANTISENSE MODULATION OF EXPRESSION OF TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTORS (TRAFs) |
| 08/01/2001 | EP1119579A1 Antisense modulation of bcl-x expression |
| 08/01/2001 | EP1119376A2 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 08/01/2001 | EP1119369A1 Vascular endothelial growth factor 3 |
| 08/01/2001 | EP1119349A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 08/01/2001 | EP1119346A2 Rna cancer vaccine and methods for its use |
| 08/01/2001 | EP0862629B1 Epithelial membrane protein-1 |
| 08/01/2001 | EP0760675B1 Compositions comprising dna damaging agents and p53 |
| 08/01/2001 | CN1306576A G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 08/01/2001 | CN1306436A Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 08/01/2001 | CN1306007A Dry cell factor |
| 07/31/2001 | US6268516 Cationic amphiphilic lipids for liposomal gene transfer |
| 07/31/2001 | US6268490 Bicyclonucleoside and oligonucleotide analogues |
| 07/31/2001 | US6268350 Polynucleotides for inhibiting metastasis and tumor cell growth |
| 07/31/2001 | US6268334 Cells include cardiovascular cells, and the peptide may be delivered in a stent to treat or prevent restinosis. |
| 07/31/2001 | US6268214 Vectors encoding a modified low affinity nerve growth factor receptor |
| 07/31/2001 | US6268213 Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy |
| 07/31/2001 | US6268172 A polynucleotide encoding a polypeptide for histidine kinase; screening and development of antibiotics for streptococcal diseases; otitis media, conjunctivitis, pneumonia, bacteremia pleural empyema, menegitis, sinusitis |
| 07/31/2001 | US6268165 Methods for the early diagnosis of ovarian cancer |
| 07/31/2001 | US6268151 Antisense modulation of macrophage migration inhibitory factor expression |
| 07/31/2001 | US6268138 Retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and making cells resistant to the chemotherapeutic agent cyclophosphamide and its derivatives and analogs |
| 07/31/2001 | US6268130 RP compositions and diagnostic uses therefor |
| 07/31/2001 | CA2218372C Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
| 07/31/2001 | CA2161136C Adenoviruses having modified fiber proteins |
| 07/31/2001 | CA2107553C Monoclonal antibodies to stem cell factor receptors |
| 07/26/2001 | WO2001053835A2 Methods for detecting cancer of the central nervous system |
| 07/26/2001 | WO2001053541A1 Antisense modulation of caspase 8 expression |
| 07/26/2001 | WO2001053540A1 Antisense modulation of pepck-cytosolic expression |
| 07/26/2001 | WO2001053528A1 Antisense inhibition of ptp1b expression |
| 07/26/2001 | WO2001053524A2 Cancer associated genes and their products |
| 07/26/2001 | WO2001053507A1 Replication competent herpes virus strains |
| 07/26/2001 | WO2001053506A2 Virus strains for the oncolytic treatment of cancer |
| 07/26/2001 | WO2001053505A2 Herpes virus strains for gene therapy |
| 07/26/2001 | WO2001053504A1 Replication deficient adenovirus vectors |
| 07/26/2001 | WO2001053491A1 Use of paramyxovirus vector in gene transfer into blood vessel |
| 07/26/2001 | WO2001053490A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom |
| 07/26/2001 | WO2001053489A1 Human gaba receptor proteins and polynucleotides encoding the same |
| 07/26/2001 | WO2001053486A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | WO2001053467A1 Recombinant flaviviruses and methods of use thereof |
| 07/26/2001 | WO2001053351A2 Apoptin bindendes protein |
| 07/26/2001 | WO2001053347A2 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 07/26/2001 | WO2001053346A1 Human cystine knot polypeptide |
| 07/26/2001 | WO2001053344A2 Chondromodulin-i related peptide |
| 07/26/2001 | WO2001053343A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | WO2001053341A1 A new polypeptide-human zinc finger protein 13 and the polynucleotide encoding it |
| 07/26/2001 | WO2001053336A1 Clostridial toxin derivatives and methods for treating pain |
| 07/26/2001 | WO2001053317A1 Antisense modulation of macrophage migration inhibitory factor expression |
| 07/26/2001 | WO2001053315A1 Antisense modulation of ara70 expression |
| 07/26/2001 | WO2001053314A1 Antisense modulation of daxx expression |
| 07/26/2001 | WO2001053313A1 Antisense modulation of smad7 expression |
| 07/26/2001 | WO2001053311A1 Antisense modulation of peroxisome proliferator-activated receptor gamma expression |
| 07/26/2001 | WO2001053310A1 Antisense modulation of caspase 3 expression |
| 07/26/2001 | WO2001052904A2 Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides |
| 07/26/2001 | WO2001052903A1 Method for nucleic acid transfection of cells |
| 07/26/2001 | WO2001052902A1 Antisense modulation of inducible nitric oxide synthase expression |
| 07/26/2001 | WO2001052901A1 Drugs for gene therapy |
| 07/26/2001 | WO2001052889A1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers |
| 07/26/2001 | WO2001052888A2 Improved dna vaccines for production-type animals |
| 07/26/2001 | WO2001052874A2 Intra-tumoral administration of il-12 encoding nucleic acid molecules |
| 07/26/2001 | WO2001052864A1 Antisense modulation of cot oncogene expression |
| 07/26/2001 | WO2001052863A1 Antisense modulation of mekk2 expression |
| 07/26/2001 | WO2001052862A1 Antisense modulation of glycogen synthase kinase 3 beta expression |
| 07/26/2001 | WO2001052639A1 Use of pro-apoptotic factors in treatment of atherosclerosis |
| 07/26/2001 | WO2001034206A8 Nucleic acid-containing complex |
| 07/26/2001 | WO2001021766A9 Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells |
| 07/26/2001 | WO2001014415A3 Egfh2 genes and gene products |
| 07/26/2001 | WO2001010902A8 Nucleoc acids and secreted polypeptides encoded thereby |
| 07/26/2001 | WO2001000784A3 Compound derived from an offset orf of the ice gene |
| 07/26/2001 | WO2000078939A3 Vectors for the treatment of tumors by gene therapy |
| 07/26/2001 | WO2000078803A3 Use of eif4e binding agents in therapy |
| 07/26/2001 | WO2000070341A3 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 07/26/2001 | WO2000055194A9 Tuberculosis antigens and methods of use therefor |
| 07/26/2001 | WO2000041566A9 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2001 | WO2000017361A3 Interferon-epsilon |
| 07/26/2001 | US20010009905 Adipocyte Complement-Related Protein encoded polypeptides, used in therapy and diagnosis, cell proliferation, cell death, energy homestasis; treatment of cancers, obesity, diabetes, heart disease, immunity |
| 07/26/2001 | US20010009904 Process of delivering a polynucleotide to a cell via the vascular system |
| 07/26/2001 | US20010009772 Transfecting cell with first polynucleotide comprising retroviral genome operably linked to first inducible transcription regulation element wherein retroviral genome is defective for self-replication, second, third polynucleotides |
| 07/26/2001 | US20010009670 Parenterally administering large liposomes comprised of phospholipids substantially free of sterol, where the liposomes pick-up cholesterol |
| 07/26/2001 | DE10001169A1 New regulatory sequences from the fascin gene, useful for providing dendritic cell-specific expression of e.g. antigens, e.g. for vaccination against tumors and infections |